CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.

Huma ShehwanaAyse G KeskusSila E OzdemirAzer A AcikgözRumeysa Biyik-SitIlgin CagnanDamla GunesErmira JahjaSahika Cingir-KokerGizem OlmezerCeren SucularliOzlen Konu

Published in: Cellular oncology (Dordrecht) (2021)

Our findings strongly associate increased expression of CHRNA5 and its co-expression network with secondary E2 signaling and a worse prognosis in breast cancer.

Keyphrases

poor prognosis
binding protein
long non coding rna
breast cancer risk
network analysis